ENTITY
Bayer

Bayer (BAYN GR)

68
Analysis
Health CareGermany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullishMonsanto Co
30 Jul 2017 15:52

CADE to Decide on Monsanto/Bayer by Year-End or Early 2018

Brazilian regulator CADE is not expected to issue a decision on the ongoing merger between German biotech giant Bayer and GMO-focused peer Monsanto...

Logo
196 Views
Share
bullishMonsanto Co
18 Jun 2017 12:00

Bayer Acquisition of Monsanto Likely to Extend into 2018, Sources Say

Industry sources believe that the Bayer acquisition of Monsanto will be delayed into 2018.  Bayer has not yet filed with Brussels authorities for...

Logo
314 Views
Share
bullishMonsanto Co
28 Apr 2017 08:09

Monsanto /​ Bayer: Horizontal Antitrust Issues

Sentiment in Monsanto continues its positive trend. After Berkshire Hathaway disclosed a 1.8% stake in February, and Monsanto and Bayer held a...

Share
27 Feb 2017 06:28

AI & Machine Learning Disrupting The Healthcare Industry

In the omnipresence of machine learning, one of the most impacted segments is healthcare. Not only is AI in healthcare at the forefront of a...

Logo
652 Views
Share
bearishMonsanto Co
09 Feb 2017 13:58

Monsanto / Bayer: International Antitrust Reviews

Antitrust regulators’ protocols and assessments of mergers differ by jurisdiction and this insight focuses almost exclusively on the international...

Share
x